{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:49:25Z","timestamp":1790196565686,"version":"4.1.0"},"reference-count":45,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"vor","delay-in-days":232,"URL":"http:\/\/www.diabetesjournals.org\/site\/license"}],"funder":[{"name":"Genesis Research Trust, UK"},{"name":"The Department of Obstetric Medicine at Women and Infants Hospital Providence RI. USA"},{"name":"National Institute for Health Research (NIHR) Biomedical Resource Centres at Imperial College London and King's College London, UK"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Quantification of changes in glucose and lipid concentrations in women with intrahepatic cholestasis of pregnancy (ICP) and uncomplicated pregnancy and study of their influence on fetal growth.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>A prospective study comparing metabolic outcomes in cholestastic and uncomplicated singleton pregnancies was undertaken at two university hospitals in the U.K. and U.S. from 2011\u20132014. A total of 26 women with ICP and 27 control pregnancies with no prior history of gestational diabetes mellitus were recruited from outpatient antenatal services and followed until delivery. Alterations in glucose, incretins, cholesterol, and triglycerides were studied using a continuous glucose monitoring (CGM) system and\/or a standard glucose tolerance test (GTT) in conjunction with GLP-1 and a fasting lipid profile. Fetal growth was quantified using adjusted birth centiles.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Maternal blood glucose concentrations were significantly increased in ICP during ambulatory CGM (P &amp;lt; 0.005) and following a GTT (P &amp;lt; 0.005). ICP is characterized by increased fasting triglycerides (P &amp;lt; 0.005) and reduced HDL cholesterol (P &amp;lt; 0.005), similar to changes observed in metabolic syndrome. The offspring of mothers with ICP had significantly larger customized birth weight centiles, adjusted for ethnicity, sex, and gestational age (P &amp;lt; 0.005).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>ICP is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. These findings may have implications regarding the future health of affected offspring.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc14-2143","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T04:47:56Z","timestamp":1418446076000},"page":"243-248","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":114,"title":["The Metabolic Profile of Intrahepatic Cholestasis of Pregnancy Is Associated With Impaired Glucose Tolerance, Dyslipidemia, and Increased Fetal Growth"],"prefix":"10.2337","volume":"38","author":[{"given":"Marcus G.","family":"Martineau","sequence":"first","affiliation":[{"name":"Maternal and Fetal Disease Group, Institute of Reproductive and Developmental Biology, Imperial College London, London, U.K."},{"name":"Division of Obstetric and Consultative Medicine, Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Raker","sequence":"additional","affiliation":[{"name":"Division of Research, Women & Infants Hospital of Rhode Island, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Dixon","sequence":"additional","affiliation":[{"name":"Maternal and Fetal Disease Group, Institute of Reproductive and Developmental Biology, Imperial College London, London, U.K."},{"name":"Women\u2019s Health Academic Centre, King's College London, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Chambers","sequence":"additional","affiliation":[{"name":"Maternal and Fetal Disease Group, Institute of Reproductive and Developmental Biology, Imperial College London, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mavis","family":"Machirori","sequence":"additional","affiliation":[{"name":"Maternal and Fetal Disease Group, Institute of Reproductive and Developmental Biology, Imperial College London, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"King","sequence":"additional","affiliation":[{"name":"Maternal and Fetal Disease Group, Institute of Reproductive and Developmental Biology, Imperial College London, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Hooks","sequence":"additional","affiliation":[{"name":"Division of Obstetric and Consultative Medicine, Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Manoharan","sequence":"additional","affiliation":[{"name":"Maternal and Fetal Disease Group, Institute of Reproductive and Developmental Biology, Imperial College London, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Obstetric and Consultative Medicine, Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Powrie","sequence":"additional","affiliation":[{"name":"Division of Obstetric and Consultative Medicine, Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Williamson","sequence":"additional","affiliation":[{"name":"Maternal and Fetal Disease Group, Institute of Reproductive and Developmental Biology, Imperial College London, London, U.K."},{"name":"Women\u2019s Health Academic Centre, King's College London, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"2022031301392390900_B1","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3748\/wjg.15.2049","article-title":"Intrahepatic cholestasis of pregnancy","volume":"15","author":"Geenes","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2022031301392390900_B2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/AOG.0000000000000346","article-title":"Intrahepatic cholestasis of pregnancy","volume":"124","author":"Williamson","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2022031301392390900_B3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep.20336","article-title":"Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates","volume":"40","author":"Glantz","year":"2004","journal-title":"Hepatology"},{"key":"2022031301392390900_B4","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/hep.26617","article-title":"Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study","volume":"59","author":"Geenes","year":"2014","journal-title":"Hepatology"},{"key":"2022031301392390900_B5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-2008-1078756","article-title":"Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy","volume":"25","author":"Lee","year":"2008","journal-title":"Am J Perinatol"},{"key":"2022031301392390900_B6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/CS20050302","article-title":"Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy","volume":"110","author":"Casta\u00f1o","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"2022031301392390900_B7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/CS20010258","article-title":"Relationship between asymptomatic hypercholanaemia of pregnancy and progesterone metabolism","volume":"102","author":"Pascual","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"2022031301392390900_B8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI25604","article-title":"Farnesoid X receptor is essential for normal glucose homeostasis","volume":"116","author":"Ma","year":"2006","journal-title":"J Clin Invest"},{"key":"2022031301392390900_B9","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1074\/jbc.M209525200","article-title":"The farnesoid X-receptor is an essential regulator of cholesterol homeostasis","volume":"278","author":"Lambert","year":"2003","journal-title":"J Biol Chem"},{"key":"2022031301392390900_B10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor","volume":"17","author":"Pineda Torra","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2022031301392390900_B11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tips.2007.03.002","article-title":"FXR: a promising target for the metabolic syndrome?","volume":"28","author":"Cariou","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"2022031301392390900_B12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"2022031301392390900_B13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijgo.2010.11.002","article-title":"Pregnancy outcome in cases of intrahepatic cholestasis of pregnancy","volume":"112","author":"Baliutavi\u010dien\u0117","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"2022031301392390900_B14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/1471-0528.12174","article-title":"Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study","volume":"120","author":"Wikstr\u00f6m Shemer","year":"2013","journal-title":"BJOG"},{"key":"2022031301392390900_B15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.AOG.0000189096.94874.9c","article-title":"Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy","volume":"107","author":"Dann","year":"2006","journal-title":"Obstet Gynecol"},{"key":"2022031301392390900_B16","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/S0022-2275(20)37471-X","article-title":"Serum squalene and noncholesterol sterols before and after delivery in normal and cholestatic pregnancy","volume":"37","author":"Nikkil\u00e4","year":"1996","journal-title":"J Lipid Res"},{"key":"2022031301392390900_B17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejogrb.2013.12.037","article-title":"Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes","volume":"176","author":"Martineau","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2022031301392390900_B18","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(09)60234-8","article-title":"Towards a new developmental synthesis: adaptive developmental plasticity and human disease","volume":"373","author":"Gluckman","year":"2009","journal-title":"Lancet"},{"key":"2022031301392390900_B19","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1172\/JCI68927","article-title":"Maternal cholestasis during pregnancy programs metabolic disease in offspring","volume":"123","author":"Papacleovoulou","year":"2013","journal-title":"J Clin Invest"},{"key":"2022031301392390900_B20","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0002-9378(89)90762-X","article-title":"Carbohydrate metabolism in the course of intrahepatic cholestasis in pregnancy","volume":"161","author":"W\u00f3jcicka-Jagodzi\u0144ska","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"2022031301392390900_B21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1089\/dia.2012.0223","article-title":"A standard approach to continuous glucose monitor data in pregnancy for the study of fetal growth and infant outcomes","volume":"15","author":"Hernandez","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"2022031301392390900_B22","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7-36: a physiological incretin in man","volume":"2","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"2022031301392390900_B23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.AOG.0000433006.09219.f1","article-title":"Practice bulletin no. 137: gestational diabetes mellitus","volume":"122","author":"American College of Obstetricians and Gynecologists","year":"2013","journal-title":"Obstet Gynecol"},{"key":"2022031301392390900_B24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0140-6736(92)91342-6","article-title":"Customised antenatal growth charts","volume":"339","author":"Gardosi","year":"1992","journal-title":"Lancet"},{"key":"2022031301392390900_B25","first-page":"1","article-title":"Studies in cholestasis of pregnancy with special reference to lipids and lipoproteins","volume":"27","author":"Johnson","year":"1973","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"2022031301392390900_B26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2009.08.001","article-title":"Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders","volume":"30","author":"Fiorucci","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"2022031301392390900_B27","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.2174\/092986711796957266","article-title":"Advances in bile acid medicinal chemistry","volume":"18","author":"Sharma","year":"2011","journal-title":"Curr Med Chem"},{"key":"2022031301392390900_B28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.21987","article-title":"Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine","volume":"47","author":"Glantz","year":"2008","journal-title":"Hepatology"},{"key":"2022031301392390900_B29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.26055","article-title":"Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a pro-cholestatic phenotype","volume":"57","author":"Abu-Hayyeh","year":"2013","journal-title":"Hepatology"},{"key":"2022031301392390900_B30","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1074\/jbc.M510258200","article-title":"The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice","volume":"281","author":"Cariou","year":"2006","journal-title":"J Biol Chem"},{"key":"2022031301392390900_B31","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031301392390900_B32","doi-asserted-by":"crossref","first-page":"23158","DOI":"10.1074\/jbc.M314322200","article-title":"Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1","volume":"279","author":"Yamagata","year":"2004","journal-title":"J Biol Chem"},{"key":"2022031301392390900_B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000149779","article-title":"Farnesoid X receptor induces GLUT4 expression through FXR response element in the GLUT4 promoter","volume":"22","author":"Shen","year":"2008","journal-title":"Cell Physiol Biochem"},{"key":"2022031301392390900_B34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbadis.2010.01.002","article-title":"The bile acid sensor FXR regulates insulin transcription and secretion","volume":"1802","author":"Renga","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2022031301392390900_B35","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/db11-0815","article-title":"Bile acids acutely stimulate insulin secretion of mouse \u03b2-cells via farnesoid X receptor activation and K(ATP) channel inhibition","volume":"61","author":"D\u00fcfer","year":"2012","journal-title":"Diabetes"},{"key":"2022031301392390900_B36","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1172\/JCI65538","article-title":"Hepatic glucose sensing is required to preserve \u03b2 cell glucose competence","volume":"123","author":"Seyer","year":"2013","journal-title":"J Clin Invest"},{"key":"2022031301392390900_B37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1476-5381.2011.01561.x","article-title":"Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion","volume":"165","author":"Parker","year":"2012","journal-title":"Br J Pharmacol"},{"key":"2022031301392390900_B38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jhep.2010.02.003","article-title":"A new life for bile acids","volume":"52","author":"Jansen","year":"2010","journal-title":"J Hepatol"},{"key":"2022031301392390900_B39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2193-1801-2-20","article-title":"Incretin secretion stimulated by ursodeoxycholic acid in healthy subjects","volume":"2","author":"Murakami","year":"2013","journal-title":"Springerplus"},{"key":"2022031301392390900_B40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00041433-199906000-00007","article-title":"Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis","volume":"10","author":"Fruchart","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"2022031301392390900_B41","first-page":"1049","article-title":"Diabetes and pregnancy; blood sugar of newborn infants during fasting and glucose administration","volume":"47","author":"Pedersen","year":"1952","journal-title":"Nord Med"},{"key":"2022031301392390900_B42","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031301392390900_B43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.beem.2010.05.006","article-title":"Disturbances in lipid metabolism in diabetic pregnancy - Are these the cause of the problem?","volume":"24","author":"Herrera","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2022031301392390900_B44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/dmrr.2275","article-title":"Through the looking glass: gestational diabetes as a predictor of maternal and offspring long-term health","volume":"28","author":"Malcolm","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031301392390900_B45","first-page":"218598","article-title":"Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of \u201cmetabolic memory.\u201d","volume-title":"Exp Diabetes Res","author":"Yessoufou","year":"2011"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/38\/2\/243\/623810\/dc142143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/38\/2\/243\/623810\/dc142143.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T05:35:37Z","timestamp":1647149737000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/38\/2\/243\/37729\/The-Metabolic-Profile-of-Intrahepatic-Cholestasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,12]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,12,12]]},"published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc14-2143","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,12]]}}}